Novozymes A/S (OTCMKTS:NVZMY) Stock Crosses Above Fifty Day Moving Average – What’s Next?

Shares of Novozymes A/S (OTCMKTS:NVZMY) passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $60.57 and traded as high as $65.79. Novozymes A/S shares last traded at $65.52, with a volume of 17,315 shares traded.

Wall Street Analysts Forecast Growth

NVZMY has been the topic of several research analyst reports. Zacks Research upgraded Novozymes A/S from a “strong sell” rating to a “hold” rating in a research note on Monday, June 8th. Kepler Capital Markets upgraded Novozymes A/S from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, May 13th. Finally, Rothschild & Co Redburn raised Novozymes A/S to a “strong-buy” rating in a report on Friday, March 27th. Two investment analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Buy”.

Novozymes A/S Price Performance

The firm has a 50-day simple moving average of $60.57 and a two-hundred day simple moving average of $60.44. The company has a market capitalization of $27.16 billion, a price-to-earnings ratio of 44.27, a P/E/G ratio of 3.03 and a beta of 0.92. The company has a current ratio of 1.67, a quick ratio of 1.03 and a debt-to-equity ratio of 0.27.

Novozymes A/S (OTCMKTS:NVZMY) last issued its quarterly earnings data on Tuesday, May 5th. The biotechnology company reported $0.51 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.82 by ($0.31). Novozymes A/S had a net margin of 14.22% and a return on equity of 6.52%. The company had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.32 billion. As a group, analysts predict that Novozymes A/S will post 2.43 earnings per share for the current fiscal year.

About Novozymes A/S

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).